{
    "nctId": "NCT05755646",
    "briefTitle": "Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial",
    "officialTitle": "Feasibility of an RCT to Investigate the Efficacy of Ice Plant Intensive Cream for the Prevention of Hand-foot Syndrome in Patients With Breast Cancer Receiving Therapy With Doxorubicin and/or Docetaxel: Pilot Randomized Controlled Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Hand-Foot Syndrome, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 36,
    "primaryOutcomeMeasure": "Number of patients that can be recruited in a 9 months time period",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer patients\n* Therapy with Doxorubicin and/or Docetaxel\n* Karnofsky performance status scale \\> 80\n* Informed consent\n\nExclusion Criteria:\n\n* Patients with previous skin disease and/or polyneuropathy\n* Intolerance or allergic reaction on at least one ingredient of Ice Plant Intensive Cream\n* Already receiving chemotherapy\n* Usage of Ice Plant Intensive Cream before trial\n* Severe physical or psychological illness due to which the patient is not able to participate in the study\n* Lack of German language skills",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}